Skip to content
Source Natural Foods & Herbal Supplements logo

Source Natural Foods & Herbal Supplements

531398 BSE
Price unavailable

Source Natural Foods & Herbal Supplements (SOURCENTRL) share price was ₹112.95 at the 28 Oct 2026 close; market capitalisation ₹72.71 Cr; P/E (TTM) 20.76; sector Healthcare. The share price fell 21.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was ₹21.42 Cr, against ₹12.10 Cr a year earlier and net profit was ₹0.74 Cr, against ₹0.63 Cr a year earlier (compared with Jun 2025). Promoters held 74.37% of Source Natural Foods & Herbal Supplements in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 53/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹112.95 −37.00 −24.67% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹72.71 Cr
P/E (TTM)
20.76
EBITDA
₹5.90 Cr
Return on Equity
13.2%
Debt to Equity
0.3
Book Value
₹11.77
EPS (TTM)
₹5.44
52W High
₹156.10
52W Low
₹96.55

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,766.5035.044,23,843 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,631.0087.412,55,673 Cr15.250.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,596.5072.161,74,836 Cr9.520.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,183.50107.881,17,977 Cr22.260.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,180.9026.281,17,795 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,340.8034.731,11,914 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,370.8032.841,10,741 Cr3.130.96%11.21%14.88%28,589 Cr3,356 Cr
Source Natural Foods & Herbal Supplements (this company)
—20.7673 Cr9.600.00%13.20%21.08%55 Cr4 Cr
Median 8 companies₹1,766.5034.891,17,886 Cr7.300.47%13.50%18.45%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

53 Average
Overall score

Data confidence 100/100

Category scores

Quality Good 57
Returns, margins, earnings quality 22% weight
Valuation Weak 37
Cheap vs sector & own history 24% weight
Growth Strong 96
Sales & profit trajectory 9% weight
Financial Health Good 60
Solvency, leverage, coverage 9% weight
Momentum Weak 43
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 12.7% over last 3 years.

Technical Indicators

Oscillators

Bullish

Bearish
0
Neutral
7
Bullish
2

Overall

Bullish

Bearish
2
Neutral
7
Bullish
10

Moving Averages

Bullish

Bearish
2
Neutral
0
Bullish
8

Growth Rate

Revenue Growth
56.44% higher than 3Y

change over 1 year

Net Income Growth
17.24% higher than 3Y

change over 1 year

Cash Flow Change
—

EBITDA Margin Change
-16.77%

change over 1 year Operating margin 5.56% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
5.58
6.89
8
6.83
8.16
10.26
10.45
16.07
12.1
16.95
20.3
21.03
21.42
Expenses
5.09
6.16
6.25
5.35
7.27
8.89
8.79
14.85
10.85
15.59
18.79
18.79
20.23
Operating Profit
0.49
0.73
1.75
1.48
0.89
1.37
1.66
1.22
1.25
1.36
1.51
2.24
1.19
OPM %
8.78%
10.6%
21.88%
21.67%
10.91%
13.35%
15.89%
7.59%
10.33%
8.02%
7.44%
10.65%
5.56%
Other Income
0.01
0
0
-0.05
0.01
0
0.01
0.06
0.01
0
0.01
0.04
0.18
Interest
0.04
0.05
0.06
0.04
0.08
0.18
0.2
0.17
0.16
0.16
0.15
0.17
0.28
Depreciation
0.1
0.43
0.26
0.26
0.26
0.26
0.25
0.25
0.25
0.26
0.26
0.1
0.1
PBT
0.36
0.25
1.43
1.13
0.56
0.93
1.22
0.86
0.85
0.94
1.11
2.01
0.99
Tax %
25%
28%
32.87%
71.68%
26.79%
10.75%
16.39%
27.91%
25.88%
26.6%
26.13%
37.81%
26.26%
Net Profit
0.27
0.19
0.96
0.32
0.42
0.84
1.02
0.63
0.63
0.7
0.82
1.24
0.74
EPS (₹)
0.42
0.3
1.49
0.5
0.65
1.3
1.58
0.98
0.98
1.09
1.27
1.93
1.15
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
6.54
10.93
15.94
10.84
12.81
13.59
24.88
21.53
19.79
27.3
44.92
70.38
79.7
Expenses
5.83
9.97
14.12
9.43
11.22
11.2
20.71
17.68
16.18
22.83
40.44
64.48
73.4
Operating Profit
0.71
0.96
1.82
1.41
1.59
2.39
4.17
3.85
3.61
4.47
4.48
5.9
6.3
OPM %
10.86%
8.78%
11.42%
13.01%
12.41%
17.59%
16.76%
17.88%
18.24%
16.37%
9.97%
8.38%
7.9%
Other Income
0
0.01
0.01
0.01
0
0.02
0.33
0.49
0.01
-0.04
0.08
0.06
0.23
Interest
0.01
0.01
0.07
0.24
0.2
0.23
0.1
0.24
0.27
0.21
0.62
0.66
0.76
Depreciation
0.54
0.49
0.35
0.35
0.34
0.34
0.37
0.42
0.62
1.04
0.36
0.38
0.72
PBT
0.16
0.47
1.41
0.83
1.05
1.84
4.03
3.68
2.73
3.18
3.58
4.92
5.05
Tax %
0%
10.64%
0.71%
3.61%
2.86%
11.41%
16.38%
33.97%
22.71%
45.28%
18.99%
30.89%
—
Net Profit
0.16
0.43
1.4
0.8
1.03
1.64
3.37
2.43
2.12
1.74
2.9
3.4
3.5
EPS (₹)
0.26
0.67
2.17
1.24
1.6
2.55
5.24
3.78
3.29
2.7
4.51
5.28
5.44
Div. Payout %
0%
0%
0%
0%
62.52%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6.1
6.44
6.44
6.44
6.44
6.44
6.44
6.44
6.44
6.44
6.44
6.44
Reserves
-0.96
-0.88
0.53
1.33
2.36
3.35
6.73
9.16
11.28
13.02
15.92
19.32
Borrowings
0.09
0.08
1.91
1.77
0.16
1.12
0.93
0.04
0.02
1.24
7.41
7.79
Other Liabilities
0.77
0.98
2.63
1.56
1.84
2.23
3.13
3.69
3.96
4.18
6.56
7.38
Total Liabilities
6
6.62
11.51
11.1
10.8
13.14
17.23
19.33
21.7
24.88
36.33
40.93
Fixed Assets
3.66
3.31
3.53
3.58
3.57
3.31
3.88
5
6.56
5.52
3.93
4.16
CWIP
0
0
0
0
0
0
0.34
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
2.34
3.31
7.98
7.52
7.23
9.83
13.01
14.33
15.14
19.36
32.4
36.77
Total Assets
6
6.62
11.51
11.1
10.8
13.14
17.23
19.33
21.7
24.88
36.33
40.93
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.38
0.38
-0.69
0.11
2.64
-0.36
4.46
-0.7
2.51
2.69
0.07
-2.49
Investing
-0.4
-0.16
-1.95
0.14
-0.31
-0.71
-2.09
0.07
0.06
0.29
-5.33
-2.36
Financing
0.11
0.01
2.06
-0.42
-1.6
0.32
0.32
-1.2
-0.53
1.19
5.4
-0.17
Net Cash Flow
0.08
0.23
-0.58
-0.18
0.74
-0.74
2.69
-1.83
2.04
4.18
0.13
-5.01
Free Cash Flow
-0.02
0.24
-1.26
-0.29
2.31
-0.44
3.2
-1.9
2.59
2.69
-0.02
-3.1
CFO/OP
54
40
-38
8
166
-15
107
-18
70
60
2
-42
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
12.84
27.72
101
139
94.88
182
87.88
131
137
100
99.46
92.68
Inventory Days
218
143
116
203
149
92.38
64.09
107
142
93.59
66.2
55.94
Days Payable
108
81.7
84.18
36.13
46.29
58.58
22.1
57.67
78.93
60.94
35.55
35.9
Cash Conversion Cycle
123
89.26
132
306
198
216
130
180
199
133
130
113
Working Capital Days
57.48
53.1
74.88
125
113
156
68.66
163
157
98.27
54.36
77.53
ROCE %
3.31%
8.83%
20.39%
11.62%
13.51%
20.84%
33.11%
26.36%
17.97%
17.9%
16.64%
17.62%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Source Natural Foods & Herbal Supplements insights

60 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

Promot.74.37%Others4.90%Public20.74%As ofSep 2026

Documents

Frequently Asked Questions about Source Natural Foods & Herbal Supplements

What does Source Natural Foods & Herbal Supplements Ltd do?
Incorporated in 1998, Source Natural Foods and Herbal Supplements Ltd deals in ayurvedic products and green energy segment.[1]
Where is Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) listed?
Source Natural Foods & Herbal Supplements Ltd trades under code 531398 on the BSE.
Which sector does Source Natural Foods & Herbal Supplements Ltd belong to?
Source Natural Foods & Herbal Supplements Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd has a market capitalisation of ₹72.71 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd trades at a PE ratio of 20.76 as of 28 Oct 2026, on earnings per share of ₹5.44, against a book value of ₹11.77 per share.
What is the 52-week high and low of Source Natural Foods & Herbal Supplements Ltd?
Over the last 52 weeks Source Natural Foods & Herbal Supplements Ltd has traded between ₹96.55 and ₹156.1 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Source Natural Foods & Herbal Supplements Ltd?
Source Natural Foods & Herbal Supplements Ltd reported a return on equity of 13.20%. Its debt-to-equity ratio is 0.30.

Company Information

Incorporated in 1998, Source Natural Foods and Herbal Supplements Ltd deals in ayurvedic products and green energy segment.[1]

Website source-natural.com
Face Value ₹ 10
Shares Outstanding 64,37,500

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531398.md for Source Natural Foods & Herbal Supplements Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month